Form 4: Integra LifeSciences Executive Mosebrook Reports Stock Disposals
SEC Form 4 Filing
Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports the disposal of common stock to cover tax obligations.
Summary
- Jeffrey Mosebrook, a Senior Vice President at Integra LifeSciences Holdings Corp, filed a Form 4 indicating changes in beneficial ownership of the company's stock.
- The report details the disposal of 111 shares and 166 shares of common stock on March 10, 2025, at a price of $22.61 per share.
- These transactions were likely to cover tax obligations related to vesting of stock awards.
- Following these disposals, Mosebrook directly owns 35,811 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of stock disposal transactions |
| 03/11/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.